These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2451265)

  • 1. Antiviral cytotoxic T lymphocyte induction and vaccination.
    Rouse BT; Norley S; Martin S
    Rev Infect Dis; 1988; 10(1):16-33. PubMed ID: 2451265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of protective immunity using minigenes.
    Whitton JL
    Ann N Y Acad Sci; 1994 Aug; 730():107-17. PubMed ID: 7521600
    [No Abstract]   [Full Text] [Related]  

  • 3. The T-lymphocyte response to varicella-zoster viral proteins.
    Arvin AM; Koropchak CM; Sharp M; Bergen R; Diaz PS
    Adv Exp Med Biol; 1990; 278():71-81. PubMed ID: 1963047
    [No Abstract]   [Full Text] [Related]  

  • 4. Five new cytotoxic T cell epitopes identified within Epstein-Barr virus nuclear antigen 3.
    Burrows SR; Gardner J; Khanna R; Steward T; Moss DJ; Rodda S; Suhrbier A
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2489-93. PubMed ID: 7521394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection.
    van der Most RG; Sette A; Oseroff C; Alexander J; Murali-Krishna K; Lau LL; Southwood S; Sidney J; Chesnut RW; Matloubian M; Ahmed R
    J Immunol; 1996 Dec; 157(12):5543-54. PubMed ID: 8955205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors.
    Ossendorp F; Mengedé E; Camps M; Filius R; Melief CJ
    J Exp Med; 1998 Mar; 187(5):693-702. PubMed ID: 9480979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying the epitope-specific T cell response to virus infections.
    Soethout EC; Meiring HD; de Jong AP; van Els CA
    Vaccine; 2007 Apr; 25(16):3200-3. PubMed ID: 17276553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of protective cytotoxic T cells with viral proteins.
    Bachmann MF; Kündig TM; Freer G; Li Y; Kang CY; Bishop DH; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1994 Sep; 24(9):2228-36. PubMed ID: 8088338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody and T cell responses to measles virus polypeptides and synthetic peptides.
    Mäkelä MJ; Ilonen J; Salmi AA
    FEMS Immunol Med Microbiol; 1993 Jan; 6(1):3-11. PubMed ID: 7682466
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthetic peptide vaccines effective in preventing virus infection.
    Ogasawara K
    Microbiol Immunol; 1999; 43(10):915-23. PubMed ID: 10585138
    [No Abstract]   [Full Text] [Related]  

  • 11. Reverse immunogenetic and polyepitopic approaches for the induction of cell-mediated immunity against bovine viral pathogens.
    Hegde NR; Srikumaran S
    Anim Health Res Rev; 2000 Dec; 1(2):103-18. PubMed ID: 11708596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rotavirus-specific cytotoxic T lymphocytes recognize overlapping epitopes in the amino-terminal region of the VP7 glycoprotein.
    Buesa J; Raga JV; Colomina J; de Souza CO; Muñoz C; Gil MT
    Virology; 1999 May; 257(2):424-37. PubMed ID: 10329553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of rhesus monkeys with synthetic peptide in a fusogenic proteoliposome elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes.
    Miller MD; Gould-Fogerite S; Shen L; Woods RM; Koenig S; Mannino RJ; Letvin NL
    J Exp Med; 1992 Dec; 176(6):1739-44. PubMed ID: 1460429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination, immunopathology, and immunity.
    Hotchin J; Hotchin LB
    Science; 1991 Jul; 253(5016):210. PubMed ID: 1712986
    [No Abstract]   [Full Text] [Related]  

  • 15. Single-chain lipopeptide vaccines for the induction of virus-specific cytotoxic T cell responses in randomly selected populations.
    Gras-Masse H
    Mol Immunol; 2001 Dec; 38(6):423-31. PubMed ID: 11741692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct priming and cross-priming contribute differentially to the induction of CD8+ CTL following exposure to vaccinia virus via different routes.
    Shen X; Wong SB; Buck CB; Zhang J; Siliciano RF
    J Immunol; 2002 Oct; 169(8):4222-9. PubMed ID: 12370352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
    Khanna R; Burrows SR; Kurilla MG; Jacob CA; Misko IS; Sculley TB; Kieff E; Moss DJ
    J Exp Med; 1992 Jul; 176(1):169-76. PubMed ID: 1377222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV immunization. Fresh pathways to follow.
    Bolognesi DP
    Nature; 1990 Apr; 344(6269):818-9. PubMed ID: 1691822
    [No Abstract]   [Full Text] [Related]  

  • 19. [The repertoire of the antigenic specificity of cytotoxic T-lymphocytes in viral infections].
    Kolontsov AA; Makarov VV
    Vopr Virusol; 1990; 35(2):97-101. PubMed ID: 1697131
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytotoxic T lymphocytes and viral evolution in primary HIV-1 infection.
    Price DA; O'callaghan CA; Whelan JA; Easterbrook PJ; Phillips RE
    Clin Sci (Lond); 1999 Dec; 97(6):707-18. PubMed ID: 10585898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.